RecruitingNCT05246098

REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI

REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or Acute Respiratory Infection


Sponsor

McMaster University

Enrollment

900 participants

Start Date

Aug 24, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Background: Many adults and some children with COVID-19 or acute respiratory infection become critically ill and need advanced life support in the Intensive Care Unit (ICU). Frailty is a medical condition of reduced function and health. Adults with frailty have a lower chance of surviving critical illness. The investigators are still learning about critically ill adults with COVID-19 or acute respiratory infection, and do not have much information on how frailty affects outcomes in critically ill children, with or without COVID-19 or acute respiratory infection. Rehabilitation can help survivors of COVID-19 or acute respiratory infection by improving strength and improve quality of life (QOL). Objectives: The main goal of this research study is to see if patients with frailty have a lower chance of surviving COVID-19 or acute respiratory infection critical illness and more health problems after survival than patients without frailty. The investigators will also study the types of rehabilitation received by patients with COVID-19 or acute respiratory infection. Methods: The investigators will include adults and children with COVID-19 or acute respiratory infection who are admitted to the ICUs that participate in the study. The investigators will gather data about each patient, including before and during their illness. Outcomes: The investigators will collect level of frailty, function, and types of therapy, or rehabilitation received by patients. In adults, the investigators are most interested in learning if frailty influences mortality, or death. In children, the investigators are most interested in whether children with COVID-19 or acute respiratory infection critical illness are more likely to develop frailty. The investigators will also study post-hospital discharge location in survivors (e.g., home, rehabilitation). Relevance: The COVID-19 pandemic is a global public health crisis. It is critical to understand how COVID-19 and other acute respiratory infection critical illness affects groups of people who are at higher risk, and the impact on outcomes that are important to patients, like functioning and QOL. The results will help policy makers plan post-hospital services for survivors, help healthcare workers understand the importance of rehabilitation practice for patients with COVID-19 or acute respiratory infection, and help researchers develop treatments to improve QOL after COVID-19 or acute respiratory infection.


Eligibility

Inclusion Criteria1

  • Adult and pediatric survivors of COVID-19 or acute respiratory infection admitted to participating intensive care units (ICUs) and PICUs. The investigators define children as less than, and adults as greater than or equal to, 18 years old, respectively. The investigators will include adults and pediatrics with a confirmed diagnosis of COVID-19, pediatric patients with MIS-C, and adults and pediatrics with suspected or proven acute respiratory infection with onset within 14 days of ICU/PICU admission and requiring invasive mechanical ventilation, non-invasive ventilation, or high flow oxygen therapy.

Exclusion Criteria1

  • Patients who were admitted to ICU for <24 hours

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(28)

Alberta Children's Hospital

Calgary, Alberta, Canada

University of Alberta

Edmonton, Alberta, Canada

Sturgeon Community Hopsital

St. Albert, Alberta, Canada

Royal Columbian Hospital

New Westminster, British Columbia, Canada

Children's Hospital of Winnipeg

Winnipeg, Manitoba, Canada

QEII Health Sciences Centre

Halifax, Nova Scotia, Canada

Izaak Walton Killam Hospital for Children

Halifax, Nova Scotia, Canada

Brantford General Hospital

Brantford, Ontario, Canada

Hamilton General Hospital

Hamilton, Ontario, Canada

St. Joseph's Healthcare Intensive Care Unit

Hamilton, Ontario, Canada

McMaster Children's Hospital

Hamilton, Ontario, Canada

Juravinski Hospital

Hamilton, Ontario, Canada

Kingston Health Sciences Centre

Kingston, Ontario, Canada

London Health Sciences Centre

London, Ontario, Canada

Children's Hospital of Eastern Ontario

Ottawa, Ontario, Canada

The Ottawa Hospital

Ottawa, Ontario, Canada

Niagara Health System

St. Catharines, Ontario, Canada

Sunnybrook Hospital

Toronto, Ontario, Canada

St. Michael's Hospital

Toronto, Ontario, Canada

The Hospital for Sick Children

Toronto, Ontario, Canada

Hôpital Hôtel-Dieu de Lévis

Lévis, Quebec, Canada

Centre hospitalier de l'Université de Montréal

Montreal, Quebec, Canada

The Centre hospitalier universitaire Sainte-Justine

Montreal, Quebec, Canada

Montreal Children's Hospital

Montreal, Quebec, Canada

Hôpital du Sacré-Cœur de Montréal

Montreal, Quebec, Canada

Institut Universitaire de Cardiologie et de Pneumologie de Québec

Québec, Quebec, Canada

Hôpital Fleurimont - Sherbrooke

Sherbrooke, Quebec, Canada

Saskatchewan Health Authority

Regina, Saskatchewan, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05246098


Related Trials